ArticleScientific reports2017

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.

Arwen F Altenburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.